Watchlist Price Alert

Inozyme Pharma Inc. (INZY)

NASDAQ: INZY · Real-Time Price · USD

1.64

0.43 (35.54%)

At close: May 02, 2025, 3:59 PM

1.63

-0.31%

After-hours: May 02, 2025, 05:58 PM EDT

Inozyme Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	21.08M	24.57M	15.23M	20.62M	34.59M	46.9M	40.84M	49.02M	32.91M	44.04M	62.62M	31.94M	23.32M	27.23M	26.24M	16.49M	28.04M	59.86M	50.86M	55.64M	31.61M	-43.16M
Short-Term Investments	92.01M	107.03M	129.29M	145.53M	154M	145.55M	99.4M	81.91M	94.95M	97.41M	88.86M	65.83M	88.48M	98.05M	111.22M	128.6M	119.66M	99.64M	13M	18.9M	15.53M	86.33M
Long-Term Investments	n/a	n/a	311K	311K	311K	311K	311K	354K	n/a	354K	379K	354K	88.48M	354K	354K	2.55M	12.2M	12.21M	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.16M	769K	458K	n/a	1.69M	1.7M	3.86M	3.81M	4.16M	3.81M	3.81M	3.81M	-84.72M	2.07M	2.08M	3.3M	3.54M	354K	3M	399K	186K	-43.16M
Receivables	467K	n/a	n/a	n/a	385K	n/a	n/a	n/a	115K	96K	106K	48K	62K	73K	95K	122K	155K	252K	82K	44K	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-106K	n/a	-62K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	311K	9.33M	8.44M	8.17M	n/a	8.41M	3.34M	3.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	120.68M	140.94M	152.96M	174.32M	196.25M	200.86M	143.59M	134.15M	131.39M	145.93M	153.75M	100.58M	115.34M	130.58M	140.96M	148.04M	150.98M	163.98M	64.66M	74.96M	47.46M	43.16M
Property-Plant & Equipment	1.35M	1.66M	1.98M	2.31M	2.59M	2.84M	3.17M	3.48M	3.64M	3.93M	4.05M	4.18M	4.44M	4.74M	4.86M	5.03M	2.65M	2.46M	846K	374K	298K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.51M	2.42M	2.75M	2.62M	4.6M	4.85M	7.34M	7.65M	7.8M	8.1M	8.24M	8.35M	8.2M	7.17M	7.3M	10.87M	18.38M	15.02M	3.85M	773K	484K	-43.16M
Total Assets	123.18M	143.36M	155.71M	176.94M	200.85M	205.7M	150.93M	141.8M	139.19M	154.02M	161.99M	108.93M	123.54M	137.75M	148.26M	158.91M	169.36M	178.99M	68.51M	75.74M	47.94M	n/a
Account Payables	2.53M	2.21M	3.53M	2.17M	1.17M	2.01M	2.01M	1.81M	2.54M	1.39M	1.34M	2.2M	2.39M	626K	796K	1.71M	3.07M	3.67M	1.4M	1.57M	901K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.81M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	14.5M	4.56M	959K	n/a	910K	886K	862K	839K	n/a	794K	773K	752K	n/a	711K	691K	672K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	12.29M	10.59M	-959K	n/a	7.86M	-886K	5.66M	7.05M	n/a	7.89M	6.01M	7.81M	6.13M	4.98M	3.35M	2.66M	279K	n/a	4.59M	3.01M	n/a	n/a
Total Current Liabilities	33.9M	18.34M	15.54M	12.41M	14.69M	12.28M	12.08M	12.58M	14.71M	13.13M	10.57M	12.26M	11.63M	8.94M	6.97M	6.83M	9.97M	9.81M	6.73M	4.91M	3.24M	n/a
Long-Term Debt	31.46M	42.06M	45.33M	45.03M	44.77M	32.06M	31.88M	24.22M	4.14M	4.07M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	46K	124K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.26M	111.8M	n/a	77.93M	n/a
Total Long-Term Liabilities	31.46M	42.23M	45.75M	45.7M	45.68M	33.21M	33.26M	25.87M	6.09M	6.11M	2.24M	2.44M	2.64M	2.83M	3.01M	3.19M	1.29M	1.26M	111.8M	n/a	77.93M	n/a
Total Liabilities	65.36M	60.57M	61.29M	58.11M	60.37M	45.49M	45.34M	38.45M	20.8M	19.24M	12.81M	14.7M	14.27M	11.77M	9.98M	10.03M	11.26M	11.08M	118.53M	4.91M	81.16M	n/a
Total Debt	46.87M	46.79M	46.71M	46.63M	46.59M	34.1M	34.12M	26.66M	6.78M	6.9M	3.01M	3.19M	3.37M	3.54M	3.7M	3.87M	1.29M	n/a	n/a	n/a	n/a	n/a
Common Stock	6K	6K	6K	6K	6K	6K	5K	4K	4K	4K	4K	2K	2K	2K	2K	2K	2K	2K	n/a	1K	n/a	n/a
Retained Earnings	-387.95M	-360.88M	-336.31M	-309.28M	-285.93M	-264.39M	-247.75M	-232.16M	-214.76M	-196.22M	-179.84M	-164.58M	-147.7M	-128.95M	-114.67M	-102.13M	-91.08M	-79.96M	-51.86M	-60.15M	-34.65M	n/a
Comprehensive Income	69K	186K	-103K	-105K	41K	-78K	51K	-36K	-205K	-477K	-397K	-129K	18K	3K	18K	12K	2K	-178.99M	13K	28K	5K	-13.88M
Shareholders Equity	57.83M	82.79M	94.42M	118.84M	140.48M	160.21M	105.59M	103.38M	118.39M	134.78M	149.18M	94.23M	109.27M	125.97M	138.27M	148.89M	158.1M	167.92M	-50.02M	70.83M	-33.22M	41.15M
Total Investments	92.01M	107.03M	129.6M	145.85M	154.31M	145.55M	99.4M	81.91M	94.95M	97.41M	88.86M	65.83M	88.48M	98.05M	111.22M	131.15M	131.86M	111.85M	13M	18.9M	15.53M	86.33M